Source: http://feedproxy.google.com/~r/HealthBusinessBlog/~3/bDWfBu0IiR0/
Wednesday 12 October 2011
Right result, wrong reason: VA boots Avastin for wet AMD
I’m a big fan of cost containment in health care. But I’m dead set against using a $50 shot of Avastin in place of a $2000 shot of Lucentis even if safety and efficacy are the same. Why? Because it has a chilling effect on innovation. To make a long story short, Avastin is a [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment